M&A Deal Summary

Tokai Carbon Acquires Tokai COBEX

On June 17, 2019, Tokai Carbon acquired manufacturer Tokai COBEX from Triton Partners for 825M EUR

Acquisition Highlights
  • This is Tokai Carbon’s 1st transaction in the Manufacturing sector.
  • This is Tokai Carbon’s largest (disclosed) transaction.
  • This is Tokai Carbon’s 1st transaction in Germany.

M&A Deal Summary

Date 2019-06-17
Target Tokai COBEX
Sector Manufacturing
Buyer(s) Tokai Carbon
Sellers(s) Triton Partners
Deal Type Add-on Acquisition
Deal Value 825M EUR

Target

Tokai COBEX

Wiesbaden, Germany
Tokai COBEX GmbH is a manufacturer of carbon and graphite products for the primary aluminum and iron making industry and other metallurgical smelting processes. Tokai COBEX’s core areas of expertise lie in the manufacture of cathodes, furnace linings, and carbon electrodes in premium quality and with maximum consistency. Tokai COBEXenjoys long-standing, trust-based partnerships with numerous customers around the world. Through innovative solutions, Tokai COBEX helps its customers create added value and optimize the total cost of ownership. A highly skilled team with years of experience in product development and application assists our customers with their technical knowledge and expertise. Tokai COBEX was formed in 2017 and is based in Wiesbaden, Germany with two plants in Poland and sales and technical services in China.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Tokai Carbon

Tokyo, Japan

Category Company
Founded 1918
Sector Chemicals
Employees4,427
Revenue 363.9B JPY (2023)
DESCRIPTION

Tokai Carbon is an entity which engages in the production and sale of a broad range of high-quality carbon and graphite products servicing numerous global customers in a wide range of industries such as steel, autos, semiconductors, and electronic components. Tokai Carbon was founded in 1918 and is based in Tokyo, Japan.


DEAL STATS #
Overall 1 of 2
Sector (Manufacturing) 1 of 1
Type (Add-on Acquisition) 1 of 2
Country (Germany) 1 of 1
Year (2019) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-04-10 Carbone Savoie International SAS

Vacquerie, France

Carbone Savoie International SAS is the management and supervision of a subsidiary that offers production, sales, and R&D of cathodes, specialty graphite products, and carbon. Carbone Savoie International was formed in 2016 and is based in Vacquerie, France.

Buy -

Seller(S) 1

SELLER

Triton Partners

Frankfurt, Germany

Investor Investor


Category Private Equity Firm
Founded 1997
PE ASSETS 15.6B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Triton Partners is an investment firm focused on investing in medium-size companies headquartered in Western and Northern Europe. This includes businesses in Germany, Switzerland, Austria, Denmark, Finland, Norway, and Sweden. Triton generally pursues market leading companies with the potential for change, as well as growth opportunities through operational improvements. Sectors of interest include business services, consumer products, consumer services, healthcare, and industrials. Triton Partners was formed in 1997 and is based in Frankfurt, Germany.


DEAL STATS #
Overall 37 of 51
Sector (Manufacturing) 2 of 5
Type (Add-on Acquisition) 22 of 28
Country (Germany) 14 of 20
Year (2019) 3 of 3
Size (of disclosed) 2 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-11 Reesink

Apeldoorn, Netherlands

Reesink is an international distributor of high-quality machines and components for agriculture, landscape maintenance, warehouse design, and civil engineering. Reesink was founded in 1786 and is based in Apeldoorn, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-27 Pharmanovia

Basildon, United Kingdom

Pharmanovia is a specialty pharmaceutical business, focused on acquiring mature branded medicines out of large cap and specialty pharma companies and developing its own niche medicines. Pharmanovia was founded in 2013 and is based in Basildon, United Kingdom.

Buy -